Trademark: 79296424
Word
AM PHARMA
Status Date
Tuesday, April 5, 2022
Registration Number
6688515
Registration Date
Tuesday, April 5, 2022
Filing Date
Monday, May 25, 2020
Published for Opposition
Tuesday, January 18, 2022
5 Pharmaceutical and medical preparations for the treatment and prevention of infectious diseases, inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergies; sanitary preparations for medical use; plasters for medical purposes, materials for medical and surgical dressings; disinfectants; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of infectious diseases, inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergies; pharmaceutical drugs for the treatment of inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergies, infectious diseases; pharmaceutical preparations for the treatment of kidney diseases and disorders
44 Services in the field of hygienic and beauty care for human beings
42 Scientific and technological services and research and design services related thereto, namely, research and design in the field of computer datacenter architecture; scientific, technological and industrial research, namely, scientific research, analysis, and reporting in the field of medicine; industrial analysis and industrial research in the field of medicine; development of technologies in the field of diagnostics, pharmaceuticals; biotechnological research related to enzymatic synthesis; testing of pharmaceuticals; quality control of goods and services; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; drug research being pharmaceutical drug development services; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical drug development; pharmaceutical product testing; development of pharmaceutical preparations and drugs; consultancy in the field of pharmaceutical research; medical research and clinical research in the field of inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergic diseases; scientific research for medical purposes, namely, conducting clinical trials; conducting clinical trials for pharmaceutical products of others
The mark consists of the wording "AM PHARMA" in blue, separated by a column formed by four green rectangles.
AM PHARMACY
The color(s) blue and green is/are claimed as a feature of the mark.
"PHARMA"
Sep 20, 2022
Final Decision Transaction Processed By Ib
Aug 25, 2022
Final Disposition Notice Sent To Ib
Aug 25, 2022
Final Disposition Processed
Jul 5, 2022
Final Disposition Notice Created, To Be Sent To Ib
Apr 10, 2022
Notification Of Possible Opposition - Processed By Ib
Apr 5, 2022
Registered-Principal Register
Mar 23, 2022
Notification Of Possible Opposition Sent To Ib
Mar 23, 2022
Notification Of Possible Opposition Created, To Be Sent To Ib
Jan 29, 2022
Notification Processed By Ib
Jan 18, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 18, 2022
Published For Opposition
Dec 29, 2021
Notification Of Possible Opposition Sent To Ib
Dec 29, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 29, 2021
Notification Of Notice Of Publication E-Mailed
Dec 10, 2021
Approved For Pub - Principal Register
Nov 11, 2021
Teas/Email Correspondence Entered
Nov 10, 2021
Correspondence Received In Law Office
Nov 10, 2021
Teas Response To Office Action Received
May 16, 2021
Notification Of Non-Final Action E-Mailed
May 16, 2021
Non-Final Action E-Mailed
May 16, 2021
Non-Final Action Written
Apr 14, 2021
Teas/Email Correspondence Entered
Apr 13, 2021
Correspondence Received In Law Office
Apr 13, 2021
Teas Response To Office Action Received
Dec 7, 2020
Refusal Processed By Ib
Nov 18, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Nov 18, 2020
Refusal Processed By Mpu
Oct 30, 2020
Application Filing Receipt Mailed
Oct 28, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Oct 27, 2020
Non-Final Action Written
Oct 26, 2020
Assigned To Examiner
Oct 26, 2020
New Application Office Supplied Data Entered In Tram
Oct 22, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
